Citation Impact
Citing Papers
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy
2014 Standout
A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis
2018
Afucosylated Antibodies Increase Activation of FcγRIIIa-Dependent Signaling Components to Intensify Processes Promoting ADCC
2014
Immune Cell–Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
2014
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
2015 StandoutScience
Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression
2014
Immunotherapy of melanoma
2013
Cancer immunotherapies targeting the PD-1 signaling pathway
2017 StandoutNobel
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
2016
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Wnt signaling in cancer
2016 Standout
Tertiary lymphoid structures in cancer and beyond
2014
VEGF targets the tumour cell
2013
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Nasopharyngeal carcinoma
2019 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
The tumor microenvironment
2020 Standout
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Evolving synergistic combinations of targeted immunotherapies to combat cancer
2015
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
2015
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
2017
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Tumor-intrinsic oncogene pathways mediating immune avoidance
2015
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
B Lymphocytes and Cancer: A Love–Hate Relationship
2016
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
2017 Standout
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
B cells, plasma cells and antibody repertoires in the tumour microenvironment
2020
Innate immune signaling and regulation in cancer immunotherapy
2016
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking
2014
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
2014
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
The Lymphatic System: Integral Roles in Immunity
2016 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Innate Immune Recognition of Cancer
2015
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity
2018
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
2017 Standout
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
2018 StandoutScience
High expression of FOXP3 in primary melanoma is associated with tumour progression
2013
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
2015 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment
2016
PD-1 pathway inhibitors: The next generation of immunotherapy for advanced melanoma
2015
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
2017 Standout
The host STING pathway at the interface of cancer and immunity
2016
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T Cells
2013 Standout
Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes
2017
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Works of Sofia M. Shea being referenced
Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
2012
Neuropilin-2: a novel biomarker for malignant melanoma?
2011
Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk
2016
T cells in the human metastatic melanoma microenvironment express site‐specific homing receptors and retention integrins
2013